A QUANTIFICATION OF EXPENDITURE ON HOSPITAL STAYS IN 5 EUROPEAN COUNTRIES
For several decades health care expenditure growth has outpaced growth in GPD and incomes throughout the developed world. The aging global population as well as the growing obesity related health epidemic indicate that this trend will continue. In 2010 17% of adults were obese and more than 50% were overweight in the European Union. While these numbers continue to grow, the recent global financial crisis suggests that the accompanying trend of growing healthcare costs is not sustainable in the long term.
In the midst of the global economic crisis many European Union member countries imposed forced austerity measures to reduce governmental spending across the board. These austerity measures proved effective in many countries and in 2010 health spending across the European Union fell by 0.6%, the first annual decline since 1975. However, health spending continued to grow in several countries including France and Spain. Spending growth even accelerated in Germany and accounted for 11.6% of GPD, second only to the Netherlands. This compares to an average of 9.0% across the EU. Accordingly, Germany's per capita healthcare spending was $4,811 in 2012, a full12% higher than the next highest EU5 country.
One of the primary drivers of healthcare costs is hospital length of stay (LOS). LOS is also commonly used to measure the efficiency of health care systems. Therefore, healthcare systems looking to reduce costs often look to reduce LOS Hospital LOS and cost per bed-day have become common indicators of overall health system efficiency. The primary objective of this study was to determine which European countries have been most successful at reducing their average LOS for five common inpatient admissions: malignant neoplasm of the breast, single spontaneous child delivery, acute myocardial infarction, cataracts, and pneumonia. This research also sought to quantify the additional cost associated with longer inpatient admissions and higher costs per bed day in order to demonstrate the potential for savings in countries that have not been as successful in reducing their average LOS if they are able to align with their peers.
A review of hospital LOS and cost data was conducted in five European countries (France, Germany, Italy, Spain and the United Kingdom), utilizing data published by the World Health Organization (WHO). An average cost of each day of hospital stay was determined for each country through a WHO database. Additionally, hospital payment systems were assessed in each country through published research to understand the motivations of healthcare providers with regards to LOS.
Objective

Methods
Results
There was little consistency in the length of stay for most conditions across countries • The difference between the longest and shortest lengths of stay for a single condition range from 138% with pneumonia to 253% with malignant neoplasm of the breast • The average length of stay in Germany for malignant neoplasm of the breast is 2.4x the next longest country and for acute myocardial infarctions it is 1.3x the next longest country • The average length of stay in Germany is above the five-country average for all five conditions
Background
The was little variability in the cost per bed-day across EU5 countries • The difference between the highest cost per bed-day in the United Kingdom and the lowest cost per bed-day in Italy was less than 17% • Germany has the second highest cost per bed-day, only 0.5% behind the United Kingdom • The average cost per bedday across all five countries is $494.35 Further research into the differences between the German healthcare system and those of the other EU member countries is necessary to identify the underlying cause of the discrepancy between average LOS in Germany and the other EU countries. Possible explanations include:
• Hospitals in Germany have a counterintuitive incentive to keep patients longer than necessary because they do not receive full reimbursement when patients are discharged unusually early compared to other patients with similar conditions and they can even be eligible for increased reimbursement when patients stay beyond the average LOS for a given DRG • German hospitals could feel less pressure to reduce the cost of healthcare because Germany weathered the global financial crisis better than most other EU countries 
